- Investing Ideas
- /
- Spanish Undiscovered Gems With Strong Fundamentals
Spanish Undiscovered Gems With Strong Fundamentals
Results
18
0 new
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
18 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
YDOA | €25.20 | 0% | -3.8% | €154.2m | n/a | PB4.5x | n/a | 3.0% | Real Estate | ||
RLIA | €0.99 | -0.6% | -6.2% | €806.2m | €1.12 | PE21.9x | n/a | 5.0% | Real Estate Management and Development | ||
PRM | €9.66 | 0.6% | -6.7% | €164.4m | €16.75 | PE14.4x | n/a | 4.6% | Healthcare | ||
YCPS | €6.95 | 0% | 5.3% | €801.8m | n/a | PE20.5x | n/a | 4.3% | Diversified Financials | ||
ATSI | €3.62 | 0% | 21.5% | €180.6m | n/a | PE24.8x | n/a | 0.3% | Software | ||
CMO | €26.00 | 0% | 33.3% | €1.6b | €28.20 | PE9.1x | n/a | 4.2% | Materials | ||
CBAV | €33.90 | 5.6% | 40.1% | €541.9m | n/a | PE14.6x | n/a | 4.6% | Healthcare | ||
PRO | €27.00 | 0% | 57.0% | €1.2b | n/a | PE28.9x | n/a | 3.3% | Consumer Services | ||
SCHST | €12.40 | 0% | n/a | €619.6m | n/a | PB2.3x | n/a | n/a | Real Estate | ||
SCBYT | €7.05 | -6.0% | n/a | €211.4m | n/a | PE65.8x | n/a | n/a | Consumer Services | ||
MCM | €13.10 | 3.1% | 16.3% | €500.2m | n/a | PE10.7x | n/a | 3.5% | Materials | ||
R4 | €13.00 | 2.4% | 26.2% | €529.0m | n/a | PE17.6x | n/a | 3.8% | Diversified Financials | ||
GSJ | €5.68 | 7.6% | 39.6% | €369.3m | €9.62 | PE11.8x | E-6.2% | 2.6% | Capital Goods | ||
CEV | €6.80 | -2.9% | 15.3% | €157.5m | n/a | PE9.1x | E-10.5% | 3.2% | Real Estate Management and Development | ||
NEA | €8.80 | 3.5% | 37.5% | €107.0m | €11.00 | PE8.1x | E6.9% | 3.1% | Capital Goods | ||
ART | €7.70 | -4.3% | 107.0% | €438.8m | €6.73 | PE28.9x | E27.7% | 1.4% | Capital Goods | ||
ENO | €16.68 | -1.1% | -10.3% | €1.4b | €23.63 | PE31x | E-30.6% | 40.6% | Capital Goods | ||
FAE | €3.54 | 2.6% | 16.3% | €1.1b | €3.78 | PE11.3x | E-0.4% | 4.4% | Pharmaceuticals & Biotech |
Page 1 of 1